Connect with us

Technology

BGL Welcomes Lekha Paranjape as a Director in Technology

Published

on

The addition of Lekha strengthens the firm’s expertise in EdTech and eCommerce software

CHICAGO, May 1, 2025 /PRNewswire/ — Brown Gibbons Lang & Company (BGL), a leading independent investment bank and financial advisory firm, is pleased to announce the addition of Lekha Paranjape as a Director within its Technology investment banking vertical. Based in Chicago, Lekha will help lead the firm’s investment banking activities in EdTech Software and eCommerce Software.

The addition of Lekha strengthens the firm’s expertise in EdTech and eCommerce software.

“We are excited that Lekha has joined us to further strengthen our coverage capabilities across the EdTech and eCommerce software sectors,” said Scott Mattson, Head of BGL’s Technology vertical. “Lekha is an excellent addition to our team and her extensive industry knowledge and transaction experience will be a great asset for our clients.”

Lekha has over 15 years of investment banking experience across the Technology ecosystem. Prior to joining BGL, Lekha was a Director at Macquarie Capital where she focused on sell-side and buy-side M&A and capital raising within the EdTech and eCommerce software sectors. Previously, she held positions at Lazard, SBI Capital Markets Limited, and Barclays. Lekha holds an MBA from the University of Michigan’s Stephen M. Ross School of Business and earned her bachelor’s degree from the Indira Gandhi Institute of Technology in New Delhi, India.

“I’m excited to join BGL’s growing Technology team,” said Paranjape. “The firm’s collaborative culture, breath of services, and market relationships are second to none, and I look forward to working with the team to deliver successful outcomes for our clients.”

Lekha’s addition to the firm is the latest in BGL’s expansion of industry coverage and senior banker headcount. Since 2022, BGL has increased its Managing Director ranks by over 90%, adding more than a dozen new sectors to its industry coverage and expanding its complementary product offerings in private capital advisory across equity, debt, and other financial advisory services, including fairness opinions, valuations, and restructuring.

About Brown Gibbons Lang & Company
Brown Gibbons Lang & Company (BGL) is a leading independent investment bank and financial advisory firm focused on the global middle market. The firm advises private and public corporations and private equity groups on mergers and acquisitions, capital marketsfinancial restructuringsbusiness valuations and opinions, and other strategic matters. BGL has investment banking offices in Boston, Chicago, Cleveland, Los Angeles, and New York, and real estate offices in Chicago and Cleveland. The firm is also a founding member of REACH Cross-Border Mergers & Acquisitions, enabling BGL to service clients in more than 30 countries around the world. Securities transactions are conducted through Brown, Gibbons, Lang & Company Securities, LLC, an affiliate of Brown Gibbons Lang & Company LLC and a registered broker-dealer and member of FINRA and SIPC. For more information, please visit www.bglco.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/bgl-welcomes-lekha-paranjape-as-a-director-in-technology-302444211.html

SOURCE Brown Gibbons Lang & Company

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

on

By

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Continue Reading

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

on

By

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger 
Gilmartin Group LLC 
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Continue Reading

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

on

By

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated

Continue Reading

Trending